Seroquel Marketing Material Meets the FDA

AstraZeneca Warned by FDA About Misleading Seroquel Marketing Material

AstraZeneca working with FDA after drug warning

FDA orders AstraZeneca to change promotions on Seroquel

These articles discuss a letter that was sent to the drug company by the FDA about some of their promotional material, and the company's response to that letter. The material in question was a fact sheet distributed to doctors along with the prescribing information.

I thought it best to just let the articles speak for themselves. If you'd like to follow the issue further, this link should do a Google News search for you.

posted by j. melinn